Lipoatrophic
Showing 1 - 25 of 51
Insulin Resistance - Type A, Insulin Resistance - Type B, Lipoatrophic Diabetes Trial in Japan (Empagliflozin Tablets)
Active, not recruiting
- Insulin Resistance - Type A
- +3 more
- Empagliflozin Tablets
-
Kobe, Hyogo, Japan
- +4 more
Jun 2, 2021
Insulin Resistance - Type A, Insulin Resistance - Type B, Lipoatrophic Diabetes Trial in Japan (Empagliflozin Tablets)
Active, not recruiting
- Insulin Resistance - Type A
- +3 more
- Empagliflozin Tablets
-
Kobe, Hyogo, Japan
- +4 more
Mar 1, 2021
Familial Partial Lipodystrophy Trial in Ann Arbor (AKCEA-ANGPTL3-LRx)
Completed
- Familial Partial Lipodystrophy
-
Ann Arbor, MichiganClinical Site
Jan 27, 2021
Lipodystrophy Trial run by the NIDDK (Metreleptin)
Completed
- Lipodystrophy
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 12, 2016
HIV Lipodystrophy Trial in Houston (Human recombinant leptin ("metreleptin"), Placebo)
Completed
- HIV Lipodystrophy
- Human recombinant leptin ("metreleptin")
- Placebo
-
Houston, TexasBaylor College of Medicine
Dec 21, 2015
Type 2 Diabetes Trial in Dhaka (Pioglitazone HCl, Metformin HCl)
Completed
- Type 2 Diabetes Mellitus
- Pioglitazone hydrochloride
- Metformin hydrochloride
-
Dhaka, BangladeshBangladesh Institute of Research and Rehabilitation in Diabetes,
Feb 26, 2014
Diabetes Trial in Worldwide (Alogliptin, Glipizide)
Completed
- Diabetes Mellitus
-
Alexander City, Alabama
- +79 more
May 22, 2013
Diabetes Trial in Amsterdam, Gothenburg (Alogliptin and Pioglitazone, Alogliptin, Placebo)
Completed
- Diabetes Mellitus
- Alogliptin and Pioglitazone
- +2 more
-
Amsterdam, Netherlands
- +1 more
May 23, 2013
Diabetes Trial in Worldwide (Alogliptin, Pioglitazone, Placebo)
After 6 Months of Treatment With Pioglitazone.
Completed
- Diabetes Mellitus
- Pioglitazone and sulphonylurea
- Pioglitazone and metformin
-
Multiple, Denmark
- +3 more
Feb 27, 2012